BRPI1011971A2 - uso de alopurinol para o tratamento de reações na pele das mãos e dos pés. - Google Patents

uso de alopurinol para o tratamento de reações na pele das mãos e dos pés.

Info

Publication number
BRPI1011971A2
BRPI1011971A2 BRPI1011971A BRPI1011971A BRPI1011971A2 BR PI1011971 A2 BRPI1011971 A2 BR PI1011971A2 BR PI1011971 A BRPI1011971 A BR PI1011971A BR PI1011971 A BRPI1011971 A BR PI1011971A BR PI1011971 A2 BRPI1011971 A2 BR PI1011971A2
Authority
BR
Brazil
Prior art keywords
allopurinol
feet
hands
treatment
skin reactions
Prior art date
Application number
BRPI1011971A
Other languages
English (en)
Portuguese (pt)
Inventor
Yolanda Rodemer
Original Assignee
Advancell Advanced In Vitro Cell Technologies S A
Nobera Pharma Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advancell Advanced In Vitro Cell Technologies S A, Nobera Pharma Sl filed Critical Advancell Advanced In Vitro Cell Technologies S A
Publication of BRPI1011971A2 publication Critical patent/BRPI1011971A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1011971A 2009-04-29 2010-04-29 uso de alopurinol para o tratamento de reações na pele das mãos e dos pés. BRPI1011971A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21489409P 2009-04-29 2009-04-29
EP09382058A EP2246057A1 (en) 2009-04-29 2009-04-29 Use of allopurinol for the treatment of hand foot skin reaction
PCT/EP2010/055806 WO2010125143A1 (en) 2009-04-29 2010-04-29 Use of allopurinol for the treatment of hand foot skin reaction

Publications (1)

Publication Number Publication Date
BRPI1011971A2 true BRPI1011971A2 (pt) 2016-04-26

Family

ID=40897536

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1011971A BRPI1011971A2 (pt) 2009-04-29 2010-04-29 uso de alopurinol para o tratamento de reações na pele das mãos e dos pés.

Country Status (22)

Country Link
US (2) US8623878B2 (cg-RX-API-DMAC7.html)
EP (2) EP2246057A1 (cg-RX-API-DMAC7.html)
JP (1) JP6007101B2 (cg-RX-API-DMAC7.html)
KR (1) KR20120049848A (cg-RX-API-DMAC7.html)
CN (1) CN102421436B (cg-RX-API-DMAC7.html)
AR (1) AR076505A1 (cg-RX-API-DMAC7.html)
AU (2) AU2010243594A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI1011971A2 (cg-RX-API-DMAC7.html)
CA (1) CA2759085C (cg-RX-API-DMAC7.html)
DK (1) DK2424538T3 (cg-RX-API-DMAC7.html)
ES (1) ES2434366T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20131070T1 (cg-RX-API-DMAC7.html)
IL (1) IL215831A (cg-RX-API-DMAC7.html)
ME (1) ME01567B (cg-RX-API-DMAC7.html)
MX (1) MX2011011529A (cg-RX-API-DMAC7.html)
NZ (1) NZ595901A (cg-RX-API-DMAC7.html)
PL (1) PL2424538T3 (cg-RX-API-DMAC7.html)
PT (1) PT2424538E (cg-RX-API-DMAC7.html)
RS (1) RS53005B (cg-RX-API-DMAC7.html)
RU (1) RU2543325C2 (cg-RX-API-DMAC7.html)
SI (1) SI2424538T1 (cg-RX-API-DMAC7.html)
WO (1) WO2010125143A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9220713B2 (en) 2009-10-16 2015-12-29 Duke University Compositions and methods for the treatment of drug-induced hand-foot syndrome
JP2014502998A (ja) * 2011-01-18 2014-02-06 ビカス セラピューティクス，エルエルシー 薬学的組成物ならびに薬学的組成物を作製および使用するための方法
JP2021506958A (ja) 2017-12-13 2021-02-22 オンクォリティ ファーマシューティカルズ チャイナ エルティーディーＯｎｑｕａｌｉｔｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｈｉｎａ Ｌｔｄ． Ｅｇｆｒ阻害に関連する疾患を予防又は治療する方法
WO2019201195A1 (zh) 2018-04-16 2019-10-24 上海岸阔医药科技有限公司 预防或治疗肿瘤疗法副作用的方法
US20200046703A1 (en) * 2018-08-09 2020-02-13 Asymmetric Therapeutics, Llc Compositions and methods for treatment of the side-effects associated with administration of therapeutic agents
CA3242908A1 (en) 2022-01-05 2023-07-13 Asymmetric Therapeutics, Llc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE SKIN DISORDERS AND OTHER SKIN CONDITIONS
KR20250056445A (ko) * 2023-10-19 2025-04-28 (주) 수파드엘릭사 수족증후군 또는 수족피부반응의 예방 또는 치료용 약학 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0278040B1 (de) 1987-02-13 1991-08-14 Pharm-Allergan Gmbh Verwendung von Pteridinen und/oder Purinen oder eines Xanthinoxidase-Hemmers zur Herstellung eines Arzneimittels zur Behandlung von genetisch bedingten degenerativen Netzhauterkrankungen
GB9218711D0 (en) 1992-09-04 1992-10-21 Salim Aws S M Skin cancer treatment
AU4974893A (en) 1992-09-04 1994-03-29 Aws Shakir Mustafa Salim Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol
JP3106817B2 (ja) 1993-11-02 2000-11-06 富士電機株式会社 漏電遮断器
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6060083A (en) 1999-04-01 2000-05-09 Topical Technologies, Inc. Topical DMSO treatment for palmar-plantar erythrodysethesia
GB0013346D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
DE60117043T2 (de) 2000-11-22 2006-07-13 Rxkinetix, Inc., Louisville Behandlung von mukositis
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
SE0100873D0 (sv) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
ATE429947T1 (de) 2001-08-29 2009-05-15 Pharmakodex Ltd Vorrichtung zur topischen verabreichung
KR100949318B1 (ko) 2001-11-29 2010-03-23 사운드 파마슈티칼스 인코퍼레이티드 화학요법의 바람직하지 않은 작용을 개선하기 위한 방법과조성물
DE10200578A1 (de) 2002-01-09 2003-07-10 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme
US6979688B2 (en) 2002-02-12 2005-12-27 Ford John P Treatment method against side-effects of chemotherapy
US20040214215A1 (en) 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
EP1631146A4 (en) 2003-06-11 2006-12-06 Novacea Inc TREATMENT OF CANCER USING ACTIVE VITAMIN COMPOUNDS ASSOCIATED WITH RADIOTHERAPEUTIC AGENTS AND TREATMENTS
EP1631297A4 (en) 2003-06-11 2007-09-05 Novacea Inc TREATMENT OF IMMUNOSTIC DISEASES WITH ACTIVE VITAMIN D COMPOUNDS ALONE OR IN COMBINATION WITH OTHER THERAPEUTICS
US20050148907A1 (en) 2003-12-24 2005-07-07 Gregory Skover Treatment of skin using a benefit agent and an apparatus
JP4405326B2 (ja) 2004-06-28 2010-01-27 株式会社東芝 ランドリー機器
PT1796660T (pt) 2004-09-17 2017-02-13 Biomas Ltd Utilização de tricloro(dioxietileno-o,o¿)telurato de amónio (as101) para a inibição da enzima de conversão da interleucina-1 beta
DE602007004849D1 (de) 2006-06-01 2010-04-01 Nobera Pharma Sl Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie

Also Published As

Publication number Publication date
AU2016228193A1 (en) 2016-11-03
CA2759085C (en) 2016-08-16
US8623878B2 (en) 2014-01-07
PL2424538T3 (pl) 2014-05-30
CN102421436A (zh) 2012-04-18
CN102421436B (zh) 2014-05-07
IL215831A (en) 2016-02-29
IL215831A0 (en) 2012-01-31
US20140080845A1 (en) 2014-03-20
EP2246057A1 (en) 2010-11-03
JP2012525358A (ja) 2012-10-22
MX2011011529A (es) 2012-02-08
ME01567B (me) 2014-04-20
EP2424538A1 (en) 2012-03-07
RS53005B (sr) 2014-04-30
DK2424538T3 (da) 2013-11-04
ES2434366T3 (es) 2013-12-16
JP6007101B2 (ja) 2016-10-12
HK1168042A1 (en) 2012-12-21
EP2424538B1 (en) 2013-08-14
SI2424538T1 (sl) 2013-12-31
HRP20131070T1 (hr) 2013-12-20
PT2424538E (pt) 2013-11-07
NZ595901A (en) 2013-11-29
AU2010243594A1 (en) 2011-11-10
CA2759085A1 (en) 2010-11-04
WO2010125143A1 (en) 2010-11-04
RU2011148355A (ru) 2013-06-10
AR076505A1 (es) 2011-06-15
RU2543325C2 (ru) 2015-02-27
US20100280051A1 (en) 2010-11-04
KR20120049848A (ko) 2012-05-17

Similar Documents

Publication Publication Date Title
BRPI1016234A2 (pt) dispositivo aplicador para uso médico e/ou cosmético.
BRPI1013698A2 (pt) métodos para tratamento com o uso de terapia de combinação
BR112012029746A2 (pt) composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação
BRPI0909251A2 (pt) Composição para o cuidado da pele
BR112012000417A2 (pt) aparelho para uso em tratamento terapêutico e/ou cosmético
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0908428A2 (pt) uso de ranozalina para tratar a dor.
PT2796457T (pt) Genz 112638 para o tratamento de doença de gaucher ou de fabry em terapia de associação
BRPI1016199A2 (pt) cobertura de ferimento e kit de tratamento de ferimentos.
BR112012004281A2 (pt) uso de metformina tratamento e prevenção de câncer
BRPI0919288A2 (pt) teriapia de combinação para tratamento de diabetes e condições relacionadas.
BR112012018969A2 (pt) disposição eletrocirúrgica instrumento eletricirurgico para utilização numa disposição eletrocirurgica e unidade de tratamento de uma disposição eletricirurgica
EP2229960A4 (en) MATERIAL FOR WOUND HEALING / SKIN RECONSTRUCTION
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
BR112013001709A2 (pt) apareçhp para a avaliação do estado da pele ou do cabelo
BRPI0812264A2 (pt) Vesícula, e, preparação externa para pele
BRPI1006733A2 (pt) kit para formação de imagem médica marcada e/ou produtos terapêuticos, agente de pré-marcação, sonda de formação de imagem, sonda terapêutica e método
LT2633077T (lt) Analitiniai būdai ir gardelės, skirti panaudoti agentų, sukeliančių žmogaus odos jautrinimą, identifikavimui
BRPI1011971A2 (pt) uso de alopurinol para o tratamento de reações na pele das mãos e dos pés.
BR112013023743A2 (pt) anticorpo de fator de tecidos humanos e usos do mesmo
BR112015014497A2 (pt) composição cosmética, método para aprimorar a característica de pele e utilização da composição.
BR112013015453A2 (pt) composição não-espumante e método para o tratamento não-terapêutico das matérias queratínicas
BRPI1014488A2 (pt) composições adequadas para o tratamento tópico de infecções fúngicas da pele e das unhas
BRPI0818766A2 (pt) N-fenil-pirrolidinilmetilpirrolidinamidas substituídas e uso terapêutico das mesmas
DK2407151T3 (da) Sammensætning til behandling af hud- og/eller neglelæsioner

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]